Tacropic®
For adults and children over 2 years of age, Tacropic® is applied in a thin layer to the affected areas of the skin. The drug can be used on any part of the body, including the face and neck, in the area of skin folds. The drug should not be applied to mucous membranes or under occlusive dressings.
Use in children (2 years and older) and adolescents under 16 years of age
Treatment should begin with the application of 0.03% Tacropic® ointment twice a day. The duration of treatment under this regimen should not exceed three weeks. Subsequently, the frequency of use is reduced to once a day, treatment continues until the lesions are completely cleared.
Use in adults and adolescents 16 years of age and older
Treatment should begin with the use of 0.1% Tacropic® ointment twice a day and continue until the lesions are completely cleared. As you improve, you can reduce the frequency of applying 0.1% ointment or switch to using 0.03% Tacropic® ointment. If symptoms of the disease recur, treatment with 0.1% Tacropic® ointment should be resumed twice a day. If the clinical picture allows, an attempt should be made to reduce the frequency of use of the drug, or use a lower dosage - 0.03% Tacropic® ointment.
Use in elderly people (65 years and older)
There are no special features for use in elderly people. Improvement is usually observed within one week from the start of therapy. If there are no signs of improvement during therapy within two weeks, a change in therapeutic tactics should be considered.
Treatment of exacerbations
Tacropic® can be used short-term or long-term in the form of periodically repeated courses of therapy. Treatment of the affected areas of the skin is carried out until the clinical manifestations of atopic dermatitis completely disappear. As a rule, improvement is observed during the first week of treatment. If signs of improvement are not observed within two weeks of starting to use the ointment, other options for further treatment should be considered. Treatment should be resumed when the first signs of exacerbation of atonic dermatitis appear.
Prevention of exacerbations
To prevent exacerbations and increase the duration of remission in patients with a history of frequent (more than 4 times a year) exacerbations of the disease, maintenance therapy with Tacropic® is recommended.
The advisability of prescribing maintenance therapy is determined by the effectiveness of previous treatment according to a standard regimen (2 times a day) for no more than 6 weeks.
During maintenance therapy, Tacropic® ointment should be applied 2 times a week (for example, on Monday and Thursday) to areas of the skin usually affected by exacerbations.
The time interval between application of the drug should be at least 2-3 days.
In adults and adolescents 16 years of age and older, 0.1% Tacropic® ointment is used, in children (2 years and older) - 0.03% Tacropic® ointment. If signs of exacerbation appear, you should proceed to the usual treatment regimen with Tacropic® ointment (see section “Treatment of exacerbations”).
After 12 months of maintenance therapy, it is necessary to evaluate the clinical dynamics and decide on the advisability of continuing the prophylactic use of Tacropic®. In children, to assess clinical dynamics, the drug should be temporarily discontinued and then the need to continue maintenance therapy should be considered.
Tacropic, 1 piece, 15 g, 0.03%, ointment for external use
For adults and children over 2 years of age, Tacropic® is applied in a thin layer to the affected areas of the skin. The drug can be used on any part of the body, including the face and neck, in the area of skin folds. The drug should not be applied to mucous membranes or under occlusive dressings.
Use in children (2 years and older) and adolescents under 16 years of age
Treatment should begin with the application of 0.03% Tacropic® ointment twice a day. The duration of treatment under this regimen should not exceed three weeks. Subsequently, the frequency of use is reduced to once a day, treatment continues until the lesions are completely cleared.
Use in adults and adolescents 16 years of age and older
Treatment should begin with the use of 0.1% Tacropic® ointment twice a day and continue until the lesions are completely cleared. As you improve, you can reduce the frequency of applying 0.1% ointment or switch to using 0.03% Tacropic® ointment. If symptoms of the disease recur, treatment with 0.1% Tacropic® ointment should be resumed twice a day. If the clinical picture allows, an attempt should be made to reduce the frequency of use of the drug, or use a lower dosage - 0.03% Tacropic® ointment.
Use in elderly people (65 years and older)
There are no special features for use in elderly people. Improvement is usually observed within one week from the start of therapy. If there are no signs of improvement during therapy within two weeks, a change in therapeutic tactics should be considered.
Treatment of exacerbations
Tacropic® can be used short-term or long-term in the form of periodically repeated courses of therapy. Treatment of the affected areas of the skin is carried out until the clinical manifestations of atopic dermatitis completely disappear. As a rule, improvement is observed during the first week of treatment. If signs of improvement are not observed within two weeks of starting to use the ointment, other options for further treatment should be considered. Treatment should be resumed when the first signs of exacerbation of atopic dermatitis appear.
Prevention of exacerbations
To prevent exacerbations and increase the duration of remission in patients with a history of frequent (more than 4 times a year) exacerbations of the disease, maintenance therapy with Tacropic® is recommended.
The advisability of prescribing maintenance therapy is determined by the effectiveness of previous treatment according to a standard regimen (2 times a day) for no more than 6 weeks.
During maintenance therapy, Tacropic® ointment should be applied 2 times a week (for example, on Monday and Thursday) to areas of the skin usually affected by exacerbations.
The time interval between application of the drug should be at least 2–3 days.
In adults and adolescents 16 years of age and older, 0.1% Tacropic® ointment is used, in children (2 years and older) - 0.03% Tacropic® ointment. If signs of exacerbation appear, you should proceed to the usual treatment regimen with Tacropic® ointment (see section “Treatment of exacerbations”).
After 12 months of maintenance therapy, it is necessary to evaluate the clinical dynamics and decide on the advisability of continuing the prophylactic use of Tacropic®. In children, to assess clinical dynamics, the drug should be temporarily discontinued and then the need to continue maintenance therapy should be considered.
Tacropic, 1 piece, 15 g, 0.1%, ointment for external use
For adults and children over 2 years of age, Tacropic® is applied in a thin layer to the affected areas of the skin. The drug can be used on any part of the body, including the face and neck, in the area of skin folds. The drug should not be applied to mucous membranes or under occlusive dressings.
Use in children (2 years and older) and adolescents under 16 years of age
Treatment should begin with the application of 0.03% Tacropic® ointment twice a day. The duration of treatment under this regimen should not exceed three weeks. Subsequently, the frequency of use is reduced to once a day, treatment continues until the lesions are completely cleared.
Use in adults and adolescents 16 years of age and older
Treatment should begin with the use of 0.1% Tacropic® ointment twice a day and continue until the lesions are completely cleared. As you improve, you can reduce the frequency of applying 0.1% ointment or switch to using 0.03% Tacropic® ointment. If symptoms of the disease recur, treatment with 0.1% Tacropic® ointment should be resumed twice a day. If the clinical picture allows, an attempt should be made to reduce the frequency of use of the drug, or use a lower dosage - 0.03% Tacropic® ointment.
Use in elderly people (65 years and older)
There are no special features for use in elderly people. Improvement is usually observed within one week from the start of therapy. If there are no signs of improvement during therapy within two weeks, a change in therapeutic tactics should be considered.
Treatment of exacerbations
Tacropic® can be used short-term or long-term in the form of periodically repeated courses of therapy. Treatment of the affected areas of the skin is carried out until the clinical manifestations of atopic dermatitis completely disappear. As a rule, improvement is observed during the first week of treatment. If signs of improvement are not observed within two weeks of starting to use the ointment, other options for further treatment should be considered. Treatment should be resumed when the first signs of exacerbation of atopic dermatitis appear.
Prevention of exacerbations
To prevent exacerbations and increase the duration of remission in patients with a history of frequent (more than 4 times a year) exacerbations of the disease, maintenance therapy with Tacropic® is recommended.
The advisability of prescribing maintenance therapy is determined by the effectiveness of previous treatment according to a standard regimen (2 times a day) for no more than 6 weeks.
During maintenance therapy, Tacropic® ointment should be applied 2 times a week (for example, on Monday and Thursday) to areas of the skin usually affected by exacerbations.
The time interval between application of the drug should be at least 2–3 days.
In adults and adolescents 16 years of age and older, 0.1% Tacropic® ointment is used, in children (2 years and older) - 0.03% Tacropic® ointment. If signs of exacerbation appear, you should proceed to the usual treatment regimen with Tacropic® ointment (see section “Treatment of exacerbations”).
After 12 months of maintenance therapy, it is necessary to evaluate the clinical dynamics and decide on the advisability of continuing the prophylactic use of Tacropic®. In children, to assess clinical dynamics, the drug should be temporarily discontinued and then the need to continue maintenance therapy should be considered.
For adults and children over 2 years of age, Tacropic® is applied in a thin layer to the affected areas of the skin. The drug can be used on any part of the body, including the face and neck, in the area of skin folds. The drug should not be applied to mucous membranes or under occlusive dressings.
Use in children (2 years and older) and adolescents under 16 years of age
Treatment should begin with the application of 0.03% Tacropic® ointment twice a day. The duration of treatment under this regimen should not exceed three weeks. Subsequently, the frequency of use is reduced to once a day, treatment continues until the lesions are completely cleared.
Use in adults and adolescents 16 years of age and older
Treatment should begin with the use of 0.1% Tacropic® ointment twice a day and continue until the lesions are completely cleared. As you improve, you can reduce the frequency of applying 0.1% ointment or switch to using 0.03% Tacropic® ointment. If symptoms of the disease recur, treatment with 0.1% Tacropic® ointment should be resumed twice a day. If the clinical picture allows, an attempt should be made to reduce the frequency of use of the drug, or use a lower dosage - 0.03% Tacropic® ointment.
Use in elderly people (65 years and older)
There are no special features for use in elderly people. Improvement is usually observed within one week from the start of therapy. If there are no signs of improvement during therapy within two weeks, a change in therapeutic tactics should be considered.
Treatment of exacerbations
Tacropic® can be used short-term or long-term in the form of periodically repeated courses of therapy. Treatment of the affected areas of the skin is carried out until the clinical manifestations of atopic dermatitis completely disappear. As a rule, improvement is observed during the first week of treatment. If signs of improvement are not observed within two weeks of starting to use the ointment, other options for further treatment should be considered. Treatment should be resumed when the first signs of exacerbation of atopic dermatitis appear.
Prevention of exacerbations
To prevent exacerbations and increase the duration of remission in patients with a history of frequent (more than 4 times a year) exacerbations of the disease, maintenance therapy with Tacropic® is recommended.
The advisability of prescribing maintenance therapy is determined by the effectiveness of previous treatment according to a standard regimen (2 times a day) for no more than 6 weeks.
During maintenance therapy, Tacropic® ointment should be applied 2 times a week (for example, on Monday and Thursday) to areas of the skin usually affected by exacerbations.
The time interval between application of the drug should be at least 2–3 days.
In adults and adolescents 16 years of age and older, 0.1% Tacropic® ointment is used, in children (2 years and older) - 0.03% Tacropic® ointment. If signs of exacerbation appear, you should proceed to the usual treatment regimen with Tacropic® ointment (see section “Treatment of exacerbations”).
After 12 months of maintenance therapy, it is necessary to evaluate the clinical dynamics and decide on the advisability of continuing the prophylactic use of Tacropic®. In children, to assess clinical dynamics, the drug should be temporarily discontinued and then the need to continue maintenance therapy should be considered.
